140 related articles for article (PubMed ID: 23507142)
1. miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma.
Chen L; Wang Q; Wang GD; Wang HS; Huang Y; Liu XM; Cai XH
FEBS Lett; 2013 May; 587(9):1366-72. PubMed ID: 23507142
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
[TBL] [Abstract][Full Text] [Related]
3. miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1.
Xu Z; Wang T
Biochem Biophys Res Commun; 2014 Jun; 449(2):190-5. PubMed ID: 24802407
[TBL] [Abstract][Full Text] [Related]
4. MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1.
Wang L; Shi M; Hou S; Ding B; Liu L; Ji X; Zhang J; Deng Y
FEBS Lett; 2012 May; 586(9):1312-7. PubMed ID: 22465663
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1.
Ji F; Zhang H; Wang Y; Li M; Xu W; Kang Y; Wang Z; Wang Z; Cheng P; Tong D; Li C; Tang H
Bone; 2013 Sep; 56(1):220-6. PubMed ID: 23756231
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X
Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-144 suppresses osteosarcoma growth and metastasis by targeting ROCK1 and ROCK2.
Wang W; Zhou X; Wei M
Oncotarget; 2015 Apr; 6(12):10297-308. PubMed ID: 25912304
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of microRNA-7 contributes to inhibition of the growth and metastasis of osteosarcoma cells through the inhibition of IGF1R.
Zhang Z; Zhao M; Wang G
J Cell Physiol; 2019 Dec; 234(12):22195-22206. PubMed ID: 31102265
[TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinase pathway in osteosarcoma.
Na KY; Kim YW; Park YK
Pathology; 2012 Oct; 44(6):540-6. PubMed ID: 22935974
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
[TBL] [Abstract][Full Text] [Related]
11. MiR-203 Determines Poor Outcome and Suppresses Tumor Growth by Targeting TBK1 in Osteosarcoma.
Liu S; Feng P
Cell Physiol Biochem; 2015; 37(5):1956-66. PubMed ID: 26584294
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells.
Ichimura A; Ruike Y; Terasawa K; Shimizu K; Tsujimoto G
Mol Pharmacol; 2010 Jun; 77(6):1016-24. PubMed ID: 20299489
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor.
Zhao X; Dou W; He L; Liang S; Tie J; Liu C; Li T; Lu Y; Mo P; Shi Y; Wu K; Nie Y; Fan D
Oncogene; 2013 Mar; 32(11):1363-72. PubMed ID: 22614005
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of microRNA-497 inhibits the proliferation, migration and invasion but increases the apoptosis of multiple myeloma cells through the MAPK/ERK signaling pathway by targeting Raf-1.
Ye CY; Zheng CP; Ying WW; Weng SS
Cell Cycle; 2018; 17(24):2666-2683. PubMed ID: 30382763
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
[TBL] [Abstract][Full Text] [Related]
17. miR-217 targeting Wnt5a in osteosarcoma functions as a potential tumor suppressor.
Wei R; Deng Z; Su J
Biomed Pharmacother; 2015 May; 72():158-64. PubMed ID: 26054690
[TBL] [Abstract][Full Text] [Related]
18. miR-671-5p Inhibits Tumor Proliferation by Blocking Cell Cycle in Osteosarcoma.
Xin C; Lu S; Li Y; Zhang Y; Tian J; Zhang S; Yang S; Gao T; Xu J
DNA Cell Biol; 2019 Sep; 38(9):996-1004. PubMed ID: 31393166
[TBL] [Abstract][Full Text] [Related]
19. miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3.
Liu LH; Li H; Li JP; Zhong H; Zhang HC; Chen J; Xiao T
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):31-8. PubMed ID: 22093834
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1.
Zhou X; Wei M; Wang W
Biochem Biophys Res Commun; 2013 Aug; 437(4):653-8. PubMed ID: 23872151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
